Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways.

Ma M, Dai J, Tang H, Xu T, Yu S, Si L, Cui C, Sheng X, Chi Z, Mao L, Wu X, Yang L, Yu H, Li S, Lian B, Tang B, Wang X, Yan X, Bai X, Zhou L, Kong Y, Guo J.

Theranostics. 2019 Jan 25;9(4):945-960. doi: 10.7150/thno.30516. eCollection 2019.


miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.

Chen F, Qi S, Zhang X, Wu J, Yang X, Wang R.

Pathol Res Pract. 2019 Apr;215(4):660-667. doi: 10.1016/j.prp.2018.12.021. Epub 2018 Dec 24.


Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1.

Lian S, Shi R, Bai T, Liu Y, Miao W, Wang H, Liu X, Fan Y.

Curr Pharm Des. 2013;19(35):6382-9.


MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.

Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR.

J Hematol Oncol. 2017 Jun 19;10(1):125. doi: 10.1186/s13045-017-0493-0. Erratum in: J Hematol Oncol. 2018 Jan 9;11(1):6.


Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.

Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C.

Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24.


MicroRNA-23a-3p promotes the development of osteoarthritis by directly targeting SMAD3 in chondrocytes.

Kang L, Yang C, Song Y, Liu W, Wang K, Li S, Zhang Y.

Biochem Biophys Res Commun. 2016 Sep 9;478(1):467-473. doi: 10.1016/j.bbrc.2016.06.071. Epub 2016 Jun 16.


MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.

Zhuang RJ, Bai XX, Liu W.

Cancer Biol Ther. 2019 Mar 12:1-15. doi: 10.1080/15384047.2019.1579960. [Epub ahead of print]


MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.

Quan J, Pan X, Li Y, Hu Y, Tao L, Li Z, Zhao L, Wang J, Li H, Lai Y, Zhou L, Lin C, Gui Y, Ye J, Zhang F, Lai Y.

Biomed Pharmacother. 2019 Feb;110:656-666. doi: 10.1016/j.biopha.2018.11.065. Epub 2018 Dec 12. Erratum in: Biomed Pharmacother. 2019 Apr;112:108755.


Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.

Zhao C, Wang S, Zhao Y, Du F, Wang W, Lv P, Qi L.

J Cell Physiol. 2019 May;234(5):6161-6172. doi: 10.1002/jcp.27393. Epub 2018 Sep 24.


Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).

Lu YF, Yu JR, Yang Z, Zhu GX, Gao P, Wang H, Chen SY, Zhang J, Liu MY, Niu Y, Wei XM, Wang W, Ye FJ, Zhang LX, Zhao Y, Sun GG.

J Exp Clin Cancer Res. 2018 Dec 4;37(1):301. doi: 10.1186/s13046-018-0966-1.


MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.

Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang YF, Wang JH, Shi M, Wang HY, Guo RP.

J Cancer Res Clin Oncol. 2017 Feb;143(2):263-273. doi: 10.1007/s00432-016-2280-7. Epub 2016 Oct 4.


MicroRNA-488-3p sensitizes malignant melanoma cells to cisplatin by targeting PRKDC.

Li N, Ma Y, Ma L, Guan Y, Ma L, Yang D.

Cell Biol Int. 2017 Jun;41(6):622-629. doi: 10.1002/cbin.10765. Epub 2017 Apr 7.


miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging.

Röck K, Tigges J, Sass S, Schütze A, Florea AM, Fender AC, Theis FJ, Krutmann J, Boege F, Fritsche E, Reifenberger G, Fischer JW.

J Invest Dermatol. 2015 Feb;135(2):369-377. doi: 10.1038/jid.2014.422. Epub 2014 Sep 29.


MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.

Jia F, Zhang Z, Zhang X.

J Cell Biochem. 2019 Apr;120(4):6420-6430. doi: 10.1002/jcb.27929. Epub 2018 Nov 28.


MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.

Wang JR, Liu B, Zhou L, Huang YX.

Cancer Biomark. 2019;24(2):159-172. doi: 10.3233/CBM-182000.


MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.

Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin X, Cheng Y.

J Exp Clin Cancer Res. 2016 Jun 4;35(1):89. doi: 10.1186/s13046-016-0368-1.


miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.

Rang Z, Yang G, Wang YW, Cui F.

Biochem Biophys Res Commun. 2016 May 27;474(2):315-320. doi: 10.1016/j.bbrc.2016.04.093. Epub 2016 Apr 20.


LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.

Zhang B, Yu L, Han N, Hu Z, Wang S, Ding L, Jiang J.

Biomed Pharmacother. 2018 Nov;107:270-282. doi: 10.1016/j.biopha.2018.07.119. Epub 2018 Aug 8. Erratum in: Biomed Pharmacother. 2019 Mar;111:1508.


miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.

Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan Y, Guan W, Zou C.

J Exp Clin Cancer Res. 2015 Nov 14;34:139. doi: 10.1186/s13046-015-0253-3.

Supplemental Content

Support Center